. . . . . . . . . . . . "[combined DRD (2) polymorphisms can be used as a pretreatment marker for response to DRD (2) antagonists at therapeutic doses, and that A1 (+) or Del (-) subjects with schizophrenia are highly sensitive to DRD (2) antagonists]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2015-08-25T14:39:11+02:00"^^ . . . . . . . . . . . "v3.0.0.0" . "v3.0.0" .